Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
  August 29, 2013
In This Edition
News Roundup: ICON Launches Monitoring Service
Articles: The Future of Risk-Based Monitoring
Blog Posts: RBM: You Can’t There from Here
Marketplace: Marketplace

Sponsored
Update in Sleep Medicine: Impact of Nonrestorative Sleep for Mental Health Definition, Diagnosis, Evaluation, Treatment and Clinical Trials
On Demand Webcast
Register Free at: www.appliedclinicaltrialsonline.com/impact

News Roundup
bullet ICON Launches New Monitoring Service
bullet TransCelerate's Methodology for RBM (video)
bullet Predictive Analytics Role in a Risk-Based Monitoring Strategy
bullet How Under-Utilized Data Becomes A Monitoring Solution

Articles
bullet The Future of Risk-Based Monitoring
bullet Risk-Based Approaches: eClinical Forum Task Force

Sponsored
Implementing a new approach to study design: what can I expect?
Live Webcast: Thursday, September 12, 2013 and 11:00 am EDT
Register Free at: www.appliedclinicaltrialsonline.com/studydesign

Blogs Posts
bullet RBM, You Can’t There from Here
bullet FDA Updates Current Thinking on Risk-Based Monitoring


Events
bullet Risk-Based Monitoring Case Studies

Marketplace

Sponsored
Medidata
"Why Monitoring Is More Than Just SDV" [White Paper] - Explore how Medidata's cloud-based tools support TransCelerate's recommended tactics for a risk-based monitoring program. Download


CHINA REPORT
China is the third largest pharmaceutical market in the world and will become the second largest ahead of Japan by 2015. Everything you need to know to do business in the country; key economic sector data and exclusive interviews from regional leaders. Read more

Follow Us

Ask The Editor

Lisa Henderson
Editor in Chief
[email protected]


Risk-Based Monitoring

Risk-Based Monitoring Conference SPOTLIGHT EVENT
Risk-Based Monitoring in Clinical Studies
Oct. 24-25, 2013
Philadelphia, PA

Download Brochure
Register

RELATED
- Snapshot Shows Targeted Site Monitoring Trend
- Risk-Based Approach to Monitoring
- Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?
More in Risk-Based Monitoring